Free accessResearch articleFirst published online 2009-06
Time Courses of Subcellular Signal Transduction and Cellular Apoptosis in Remote Viable Myocardium of Rat Left Ventricles Following Acute Myocardial Infarction: Role of Pharmacomodulation
We tested hypothesis that acute myocardial infarction (AMI) induces cellular apoptosis and serial changes of protein kinase C epsilon (PKC-e) and p38 mitogen-activated protein kinase (p38 MAPK), and tested cardio-protective effect of losartan in this condition. The rats were assigned to group A (sacrificed on day 2), group B (sacrificed on day 5), and group C (sacrificed on day 14). Rats in each group were further randomized into the following groups: AMI (ligation of left coronary artery) without losartan (AMI-L0); AMI with losartan 20 mg/ kg/d (AMI-L1); and sham groups (L0 and L1). The PKC-e expression in membrane compartment was increased in AMI-L1 group than in other groups on day 5 and in AMI groups than in sham groups on day 14 (P < .01). Phosphorylated form of cytosolic p38 MAPK level was increased in AMI-L1 than in other groups on day 14 (P < .05). Furthermore, 14-day left ventricular ejection fraction was higher and cellular apoptosis was lower in AMI-L1 group than in AMI-L0 group (P < .0001).
Murray GJL , Lopez ADGlobal mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. Lancet. 1997;349:1436-1442.
2.
Murray GJL , Lopez ADMortality by cause for eight regions of the word: Global Burden of Disease Study. Lancet. 1997;349:1269-1276.
3.
Chen KRStress pathways and heart failure. Cell. 1999 ;98:555-558.
4.
Bloom NV, Leor J., Ohad DG, et al. Cytotoxic T lymphocytes are activated following myocardial infarction and can recognize and kill healthy myocytes in vitro. J Mol Cell Cardiol. 2000;32:2141-2149.
5.
Erlebacher JA , Weiss JL, Weisfeldt ML, Bulkley BHEarly dilatation of the infarcted segment in acute trans-mural myocardial infarction: role of infarct expansion in acute left ventricular enlargement. J Am Coll Cardiol. 1984;4:201-208.
6.
Pfeffer MA, Pfeffer JMVentricular enlargement and reduced survival after myocardial infarction . Circulation. 1987;75(5 Pt 2):IV93-IV97. Review.
7.
Pfeffer MA, Braunwald E., Moye LA, et al. for the SAVE investigators.Effect of captopril on mortality in patients with left ventricular dysfunction after myocardial infarction: results of the Survival and Ventricular Enlargement Trial. N Engl J Med. 1992;327:669-677.
8.
Cohn JN, Ferrari R., Sharpe N.Cardiac remodeling: concepts and clinical implications. J Am Coll Cardiol. 2000;35:569-582.
9.
Pfeffer MA, Lamas GA, Vaughan DE, Parisi AF, Braunwald E.Effect of captopril on progressive ventricular dilatation after anterior myocardial infarction. N Engl J Med. 1988;319:80-86.
10.
Mann DLMechanism and models in heart failure. Circulation . 1999;100:999-1008.
11.
Oppenheim RWCell death during development of the nervous system. Annu Rev Neurosci. 1991;14:453-459.
12.
Raff MC, Bares BA, Burne JF, Coles HS, Ishizaki Y., Jacobson MDProgrammed cell death and the control of cell survival: lessons from the nervous system. Science. 1993;262:695-700.
13.
Halliwell B.Free radicals, reactive oxygen species and human disease: a critical evaluation with special reference to atherosclerosis . Br J Exp Pathol. 1989;70: 737-757.
14.
Shacter E., Beecham EJ, Covey JM, Kohn KW, Potter M.Activated neutrophil induced prolonged DNA damage in neighboring cells . Carcinogenesis. 1998;9: 2297-2304.
15.
Xia Z., Dickens M., Raingeaud J., Davis RJ, Greenberg MEOpposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science. 1995;270: 1326-1331.
16.
Wang X., Martindale JL, Liu Y., Holbrook NJThe cellular response to oxidative stress: influence of mitogen-activated protein kinase signaling pathways on cell survival. Biochem J. 1998;333:291-300.
17.
Fukai MU, Alexander RW, Akers M., Griendling KKp38 mitogen-activated protein kinase is a critical component of the redox-sensitive signaling pathways activated by angiotensin II. J Biol Chem . 1998;273:15022-15029.
18.
Albert CJ, Ford DAProtein kinase C translocation and PKC-dependent protein phosphorylation during myocardial ischemia. Am J Physiol. 1999;276(2 Pt 2): H642-H650.
19.
Baines CP, Pass JM, Ping P.Protein kinases and kinase-modulated effectors in the late phase of ischemic preconditioning. Basic Res Cardiol. 2001;96:207-218.
20.
Inagaki K., Hahn HS, Dorn II GW, Mochly-Rosen S.Additive protection of the ischemic heart ex vivo by combined treatment with δ-protein kinase C inhibitor and e-protein kinase C activator. Circulation . 2003;108: 869-875.
21.
Ping P., Zhang J., Qiu Y., et al. Ischemic preconditioning induces selective translocation of protein kinase C isoforms e and η in the heart of conscious rabbits without subcellular redistribution of total protein kinase C activity. Circ Res. 1997;81:404-414.
22.
Ping P., Takano H., Zhang J., et al. Isoform-selective activation of protein kinase C by nitric oxide in the heart of conscious rabbits: a signaling mechanism for both nitric oxide-induced preconditioning. Circ Res. 1999;84: 587-604.
23.
Vondriska TM , Klein JB, Ping P.Use of functional proteomics to investigate PKC-e-mediated cardioprotection: the signaling module hypothesis. Am J Physiol. 2001;280: H1434-H1441.
24.
Dickstein K. , Kjekshus J.Effects of losartan and captopril on mortality and morbidity in high-risk patients after acute myocardial infarction: the OPTIMAAL randomised trial . Lancet. 2002;360:752-760.
25.
Schieffer B. , Wirger A., Meybrunn M., et al. Comparative effects of chronic angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade on cardiac remodeling after myocardial infarction in the rat. Circulation. 1994;89:2273-2282.
26.
Scarabelli TM, Knight R., Stephanou A., et al. Clinical implications of apoptosis in ischemic myocardium. Curr Probl Cardiol. 2006;31:181-264.
27.
Daniels MCG , Keller RS, De Tombe PPLosartan prevents contractile dysfunction in rat myocardium after left ventricular infarction. Am J Physiol Heart Circ Physiol. 2001;281:H2150-H2158.
28.
Litwin SE, Katz SE, Morgan JP, Douglas PSSerial echocardiographic assessment of left ventricular geometry and function after large myocardial infarction in the rat. Circulation . 1994;89:345-354.
29.
Sahn DJ, DeMaria A., Kisslo J., Weyman A.Recommendations of regarding quantification in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation . 1978;58:1072-1083.
30.
Mueller C., Buettner HJ, Hodgson JM, et al. Inflammation and long-term mortality after non-ST elevation acute coronary syndrome treated with a very early invasive strategy in 1042 consecutive patients. Circulation. 2002;105:1412-1415.
31.
Lagrand WK, Niessen HW, Wolbink GJ, et al. C-reactive protein colocalizes with complement in human hearts during acute myocardial infarction. Circulation. 1997;95:97-103.
32.
Nian M., Lee P., Khaper N., Liu P.Inflammatory cytokines and postmyocardial infarction remodeling. Circ Res. 2004;94:1543-1553.
33.
Yip HK, Wu CJ, Chang HW, et al. Levels and values of serum high-sensitivity C-reactive protein within 6 hours after the onset of acute myocardial infarction. Chest. 2004;126:1417-1422.
34.
Suleiman M. , Khatib R., Agmon Y., et al. Early inflammation and risk of long-term development of heart failure and mortality in survivors of acute myocardial infarction: predictive role of C-reactive protein. J Am Coll Cardiol. 2006;47:962-968.
35.
Yousef AA, Chang LT, Hang CL, et al. Level and value of interleukin-18 in patients with acute myocardial infarction undergoing primary coronary angioplasty. Circ J . 2007;71:703-708.
36.
Deten A., Volz HC, Briest W., Zimmer HCCardiac cytokine expression is upregulated in the acute phase after myocardial infarction. Experimental studies in rats. Cardiovascular Res . 2002;55:329-340.
37.
Irwin MW, Mak S., Mann DL, et al. Tissue expression and immunolocalization of tumor necrosis factor-alpha in postinfarction dysfunctional myocardium. Circulation. 1999;99:1492-1498.
38.
Otani H., Matsuhisa S., Akita Y., et al. Role of mechanical stress in the form of cardiomyocyte death during the early phase of reperfusion. Circ J. 2006;70: 1344-1355.
39.
Ottani F., Galvani M., Ferrini D., et al. Prodromal angina limits infarct size: a role for ischemic preconditioning . Circulation. 1995;91:291-297.
40.
Anzai T., Yoshikawa T., Asakura Y., et al. Preinfarction angina as a major predictor of left ventricular function and long-term prognosis after first Q wave myocardial infarction . J Am Coll Cardiol. 1995;26:319-327.
41.
Shiraki H., Yoshikawa T., Anzai T., et al. Association between preinfarction angina and lower risk of right ventricular infarction. N Engl J Med. 1998 ;338: 941-947.
42.
Bogoyevitch MA, Gillespie-Brown J., Ketterman AJ, et al. Stimulation of the stress-activated mitogen-activated protein kinase subfamilies in perfused heart: p38/RK mitogen-activated protein kinases and c-jun n-terminal kinases are activated by ischemia/reperfusion. Circ Res. 1996;79:162-173.
43.
Minutoli L. , Antonuccio P., Polito F., et al. Involvement of mitogen-activated protein kinases (MAPKs) during testicular ischemia-reperfusion injury in nuclear factor-κB knock-out mice. Life Sci. 2007;81:413-422.
44.
Chakir K., Daya SK, Tunin RS, et al. Reversal of global apoptosis and regional stress kinase activation by cardiac synchronization. Circulation. 2008 ;117: 1369-1377.
